Omega-3 Fatty Acids

Provides robust anti-inflammatory activity through the production of specialized pro-resolving mediators (resolvins, protectins, and maresins). Helps manage chronic inflammatory skin conditions including atopic dermatitis, psoriasis, and acne. Supports skin barrier function by influencing epidermal lipid metabolism and membrane composition. Reduces UV-induced inflammation and may attenuate photoaging when used as part of a comprehensive sun protection approach. Promotes wound healing by modulating inflammatory cell recruitment and supporting tissue remodeling. Helps regulate sebum production, potentially reducing acne severity when used systemically or topically.

For topical use, apply omega-3-rich oils or formulations containing EPA and DHA to cleansed skin. Common topical sources include marine-derived oils (algae oil for vegan options, fish oil derivatives), as well as formulated serums containing purified EPA and DHA esters. Use morning and evening for anti-inflammatory and barrier-supporting benefits. For maximum anti-inflammatory efficacy, combine topical application with dietary omega-3 intake through fatty fish, algae supplements, or fish oil capsules. Allow complete absorption before layering additional products. Pair with antioxidant-rich serums (vitamin C, vitamin E) to protect against oxidation of the polyunsaturated fatty acid chains.

A substantial body of research supports the anti-inflammatory and skin-protective properties of omega-3 fatty acids. Randomized controlled trials have demonstrated that oral omega-3 supplementation reduces UV-induced erythema, lowers inflammatory cytokine levels in the skin, and improves clinical outcomes in atopic dermatitis and psoriasis. Studies published in the American Journal of Clinical Nutrition and the British Journal of Dermatology confirm that EPA supplementation raises the minimal erythema dose (MED), providing a degree of systemic photoprotection. Topical studies, while fewer in number, have shown that EPA and DHA can reduce PGE2 production in UV-irradiated skin and improve barrier function in damaged epidermis. The discovery of specialized pro-resolving mediators derived from EPA and DHA, as reported in Nature and the Journal of Experimental Medicine, has provided a mechanistic basis for the anti-inflammatory effects observed clinically. Meta-analyses of omega-3 supplementation trials in dermatology consistently report modest but significant improvements in inflammatory skin disease severity scores.